Kane Biotech Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States
WINNIPEG, Manitoba, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) today announced the engagement of Dave D. Hood, President and Chief Executive Officer of DH3 & Associates, as a …